Schriever CA - Search Results

1

Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?

Schriever CA, Danziger LH. Schriever CA, et al. Clin Infect Dis. 2020 Jun 24;71(1):87-88. doi: 10.1093/cid/ciz814. Clin Infect Dis. 2020. PMID: 31584630 No abstract available.

2

Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.

Sprandel KA, Schriever CA, Pendland SL, Quinn JP, Gotfried MH, Hackett S, Graham MB, Danziger LH, Rodvold KA. Sprandel KA, et al. Among authors: schriever ca. Antimicrob Agents Chemother. 2004 Dec;48(12):4597-605. doi: 10.1128/AAC.48.12.4597-4605.2004. Antimicrob Agents Chemother. 2004. PMID: 15561831 Free PMC article. Clinical Trial.

3

The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosis.

Jain R, Schriever CA, Danziger LH, Cho SH, Rubinstein I. Jain R, et al. Among authors: schriever ca. Respiration. 2007;74(3):329-33. doi: 10.1159/000101786. Respiration. 2007. PMID: 17534131

4

Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes.

Jung R, Messick CR, Pendland SL, Tesoro EP, Losendahl KJ, Schriever CA, Danziger LH. Jung R, et al. Among authors: schriever ca. Antimicrob Agents Chemother. 2000 Mar;44(3):778-9. doi: 10.1128/AAC.44.3.778-779.2000. Antimicrob Agents Chemother. 2000. PMID: 10681358 Free PMC article.

5

Daptomycin: a novel cyclic lipopeptide antimicrobial.

Schriever CA, Fernández C, Rodvold KA, Danziger LH. Schriever CA, et al. Am J Health Syst Pharm. 2005 Jun 1;62(11):1145-58. doi: 10.1093/ajhp/62.11.1145. Am J Health Syst Pharm. 2005. PMID: 15914875 Review.

6

Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.

Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN. Johnson S, et al. Clin Infect Dis. 2007 Mar 15;44(6):846-8. doi: 10.1086/511870. Epub 2007 Feb 2. Clin Infect Dis. 2007. PMID: 17304459

7

In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis.

Pendland SL, Jung R, Messick CR, Schriever CA, Patka J. Pendland SL, et al. Among authors: schriever ca. Diagn Microbiol Infect Dis. 2002 Jun;43(2):149-56. doi: 10.1016/s0732-8893(02)00382-6. Diagn Microbiol Infect Dis. 2002. PMID: 12088623

8

In-vitro activity of gatifloxacin, a novel fluoroquinolone, compared with that of ciprofloxacin against Legionella spp.

Pendland SL, Losnedahl KJ, Schriever CA. Pendland SL, et al. Among authors: schriever ca. J Antimicrob Chemother. 1999 Aug;44(2):295-7. doi: 10.1093/jac/44.2.295. J Antimicrob Chemother. 1999. PMID: 10473243 No abstract available.

9

Long-term montelukast therapy in moderate to severe COPD--a preliminary observation.

Rubinstein I, Kumar B, Schriever C. Rubinstein I, et al. Respir Med. 2004 Feb;98(2):134-8. doi: 10.1016/j.rmed.2003.09.003. Respir Med. 2004. PMID: 14971876 Free article.

10

In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis.

Messick CR, Pendland SL, Moshirfar M, Fiscella RG, Losnedahl KJ, Schriever CA, Schreckenberger PC. Messick CR, et al. Among authors: schriever ca. J Antimicrob Chemother. 1999 Aug;44(2):297-8. doi: 10.1093/jac/44.2.297. J Antimicrob Chemother. 1999. PMID: 10473244 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters